Previous studies have confirmed ANLN and ASPM as risk factors for the prognosis of patients with BLCA through silico data analysis (Chen et al., 2019; Wang et al., 2019; Xu et al., 2019; Li et al., 2020; Liu et al., 2021b). Here, ASPM is linked to bladder transitional cell carcinoma.